WS
MTEM

Wedbush Securities’s Molecular Templates, Inc. MTEM Stock Holding History

Wedbush Securities’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-135
Closed -$9K – 884
2017
Q2 		$9K Hold
135
– – ﹤0.01% 834
2017
Q1 		$13K Buy
+135
New +$12.6K ﹤0.01% 830
2016
Q3 		– Sell
-145
Closed -$15K – 875
2016
Q2 		$15K Sell
145
-19
-12% -$1.36K ﹤0.01% 771
2016
Q1 		$12K Hold
164
– – ﹤0.01% 744
2015
Q4 		$13K Buy
+164
New +$80.9K ﹤0.01% 728

Other funds holding MTEM

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IBT
International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wedbush Securities's MTEM Position: Q3 2017 in Review

Wedbush Securities sold out of Molecular Templates, Inc. (MTEM) in Q3 2017, closing a stake of 135 shares — an estimated $9K sold.

Wedbush Securities first reported a position in MTEM in Q4 2015 and held it in 5 quarters. The position peaked at $15K in Q2 2016. 29 funds tracked by Wall St. Rank hold MTEM as of Q3 2017.

  • Wedbush Securities reported no remaining Molecular Templates, Inc. position as of Q3 2017 after selling out during the quarter.
  • Wedbush Securities sold 135 Molecular Templates, Inc. shares in Q3 2017, an estimated $9K.
  • Wedbush Securities first reported a position in Molecular Templates, Inc. in Q4 2015 and held it in 5 quarters.
  • Wedbush Securities's Molecular Templates, Inc. position peaked at $15K in Q2 2016.
  • 29 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2017.

Based on Wedbush Securities's 13F filing for Q3 2017, filed 31 Oct 2017.